A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: NNC0268-0965; Drug: insulin glargine Sponsor: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials